242 related articles for article (PubMed ID: 32104684)
41. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Von Schulz-Hausmann SA; Schmeel LC; Schmeel FC; Schmidt-Wolf IG
Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
[TBL] [Abstract][Full Text] [Related]
42. Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling.
Zi X; Lusch A; Blair CA; Okhunov Z; Yokoyama NN; Liu S; Baker M; Huynh V; Landman J
Oncotarget; 2016 Aug; 7(33):53277-53288. PubMed ID: 27409168
[TBL] [Abstract][Full Text] [Related]
43. PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation.
Covey TM; Kaur S; Tan Ong T; Proffitt KD; Wu Y; Tan P; Virshup DM
PLoS One; 2012; 7(4):e34532. PubMed ID: 22509316
[TBL] [Abstract][Full Text] [Related]
44. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
Song X; Liu J; Liu B; Piao C; Kong C; Li Z
Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
[TBL] [Abstract][Full Text] [Related]
45. Precise regulation of porcupine activity is required for physiological Wnt signaling.
Proffitt KD; Virshup DM
J Biol Chem; 2012 Oct; 287(41):34167-78. PubMed ID: 22888000
[TBL] [Abstract][Full Text] [Related]
46. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
47. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
48. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
[TBL] [Abstract][Full Text] [Related]
49. Stereoselective fatty acylation is essential for the release of lipidated WNT proteins from the acyltransferase Porcupine (PORCN).
Tuladhar R; Yarravarapu N; Ma Y; Zhang C; Herbert J; Kim J; Chen C; Lum L
J Biol Chem; 2019 Apr; 294(16):6273-6282. PubMed ID: 30737280
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells.
Zhai X; Wu Y; Zhang D; Chong T; Zhao J
Biomed Pharmacother; 2017 Jul; 91():54-59. PubMed ID: 28448870
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis.
Peña-Oyarzún D; Flores T; Torres VA; Quest AFG; Lobos-González L; Kretschmar C; Contreras P; Maturana-Ramírez A; Criollo A; Reyes M
Clin Cancer Res; 2024 Jan; 30(1):209-223. PubMed ID: 37812478
[TBL] [Abstract][Full Text] [Related]
52. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
[TBL] [Abstract][Full Text] [Related]
53. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition.
Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B
Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269
[TBL] [Abstract][Full Text] [Related]
54. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
[TBL] [Abstract][Full Text] [Related]
55. Modulating Wnt signaling at the root: Porcupine and Wnt acylation.
Torres VI; Godoy JA; Inestrosa NC
Pharmacol Ther; 2019 Jun; 198():34-45. PubMed ID: 30790642
[TBL] [Abstract][Full Text] [Related]
56. Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways.
Luan Y; Liu J; Liu X; Xue X; Kong F; Sun C; Wang J; Liu L; Jia H
Int J Oncol; 2016 Oct; 49(4):1704-12. PubMed ID: 27633040
[TBL] [Abstract][Full Text] [Related]
57. Wnt addiction of genetically defined cancers reversed by PORCN inhibition.
Madan B; Ke Z; Harmston N; Ho SY; Frois AO; Alam J; Jeyaraj DA; Pendharkar V; Ghosh K; Virshup IH; Manoharan V; Ong EH; Sangthongpitag K; Hill J; Petretto E; Keller TH; Lee MA; Matter A; Virshup DM
Oncogene; 2016 Apr; 35(17):2197-207. PubMed ID: 26257057
[TBL] [Abstract][Full Text] [Related]
58. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J
BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618
[TBL] [Abstract][Full Text] [Related]
59. HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.
Wu F; Wu S; Tong H; He W; Gou X
Int J Oncol; 2019 Jun; 54(6):2095-2105. PubMed ID: 31081053
[TBL] [Abstract][Full Text] [Related]
60. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]